Cost-effectiveness of increasing vaccination in high-risk adults aged 18–64 Years: a model-based decision analysis

Cost-effectiveness of increasing vaccination in high-risk adults aged 18–64 Years: a model-based decision analysis

Abstract Background Adults aged 18–64 years with comorbid conditions are at high risk for complications of certain vaccine-preventable diseases, including influenza and pneumococcal disease. The 4 Pillars™ Practice Transformation Program (4 Pillars Program) increases uptake of pneumococcal polysacch...

Full description

Bibliographic Details
Main Authors: Angela R. Wateska, Mary Patricia Nowalk, Richard K. Zimmerman, Kenneth J. Smith, Chyongchiou J. Lin
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Infectious Diseases
Subjects:
High-risk adults
Pneumococcal vaccine
Influenza vaccine
Tdap vaccine
Primary care
Adult vaccination
Online Access:http://link.springer.com/article/10.1186/s12879-018-2967-2

Internet

http://link.springer.com/article/10.1186/s12879-018-2967-2

Similar Items